NASDAQ

Polaryx Therapeutics, Inc. (PLYX)

♥ 619 Thanks from members

Live price chart, market sentiment, and community perspectives for Polaryx Therapeutics, Inc. (NASDAQ: PLYX).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Health CareIndustry: BiotechnologyFounder: Polaryx Therapeutics Scientific FoundersLeadership: Alexandros Makriyannis (CEO)Holder: Venture Capital FundsHolder: Private InvestorsPLX-100CNS Disease TherapeuticsLysosomal Storage Disorder Treatments#PLYX#Polaryx Therapeutics#Rare Disease Biotech#CNS Therapeutics#NASDAQ PLYX